Setlai, B.P.; Mkhize-Kwitshana, Z.L.; Mehrotra, R.; Mulaudzi, T.V.; Dlamini, Z.
Microbiomes, Epigenomics, Immune Response, and Splicing Signatures Interplay: Potential Use of Combination of Regulatory Pathways as Targets for Malignant Mesothelioma. Int. J. Mol. Sci. 2022, 23, 8991.
https://doi.org/10.3390/ijms23168991
AMA Style
Setlai BP, Mkhize-Kwitshana ZL, Mehrotra R, Mulaudzi TV, Dlamini Z.
Microbiomes, Epigenomics, Immune Response, and Splicing Signatures Interplay: Potential Use of Combination of Regulatory Pathways as Targets for Malignant Mesothelioma. International Journal of Molecular Sciences. 2022; 23(16):8991.
https://doi.org/10.3390/ijms23168991
Chicago/Turabian Style
Setlai, Botle Precious, Zilungile Lynette Mkhize-Kwitshana, Ravi Mehrotra, Thanyani Victor Mulaudzi, and Zodwa Dlamini.
2022. "Microbiomes, Epigenomics, Immune Response, and Splicing Signatures Interplay: Potential Use of Combination of Regulatory Pathways as Targets for Malignant Mesothelioma" International Journal of Molecular Sciences 23, no. 16: 8991.
https://doi.org/10.3390/ijms23168991
APA Style
Setlai, B. P., Mkhize-Kwitshana, Z. L., Mehrotra, R., Mulaudzi, T. V., & Dlamini, Z.
(2022). Microbiomes, Epigenomics, Immune Response, and Splicing Signatures Interplay: Potential Use of Combination of Regulatory Pathways as Targets for Malignant Mesothelioma. International Journal of Molecular Sciences, 23(16), 8991.
https://doi.org/10.3390/ijms23168991
